Click for best price
Preventable Vaccines Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Preventable Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Preventable Vaccines. This report contains market size and forecasts of Preventable Vaccines in global, including the following market information:
Global Preventable Vaccines Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Preventable Vaccines Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Preventable Vaccines companies in 2022 (%)
The global Preventable Vaccines market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Adult Preventable Vaccines Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Preventable Vaccines include GlaxoSmithKline, Merck, Novartis, Pfizer, Sanofi, Takeda Pharmaceutical, Abbott, Roche and AstraZeneca, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Preventable Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Preventable Vaccines Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Preventable Vaccines Market Segment Percentages, by Type, 2022 (%)
Adult Preventable Vaccines
Pediatric Preventable Vaccines
Global Preventable Vaccines Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Preventable Vaccines Market Segment Percentages, by Application, 2022 (%)
Bacterial Diseases
Virus Diseases
Global Preventable Vaccines Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Preventable Vaccines Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Preventable Vaccines revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Preventable Vaccines revenues share in global market, 2022 (%)
Key companies Preventable Vaccines sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Preventable Vaccines sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline
Merck
Novartis
Pfizer
Sanofi
Takeda Pharmaceutical
Abbott
Roche
AstraZeneca
Mitsubishi Tanabe Pharma
Lupin
Serum Institute of India
LG Life Sciences
S K Chemicals
Shenzhen Kangtai Biological Products
Sinovac Biotech
Janssen Pharmaceuticals
Crucell
Bavarian Nordic
Baxter
Bharat Biotech
Dynavax
Bausch Health
Protein Sciences
Panacea Biotec
Outline of Major Chapters:
Chapter 1: Introduces the definition of Preventable Vaccines, market overview.
Chapter 2: Global Preventable Vaccines market size in revenue and volume.
Chapter 3: Detailed analysis of Preventable Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Preventable Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Preventable Vaccines capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Preventable Vaccines Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
128 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Preventable Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Preventable Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Preventable Vaccines Overall Market Size
2.1 Global Preventable Vaccines Market Size: 2022 VS 2029
2.2 Global Preventable Vaccines Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Preventable Vaccines Sales: 2018-2029
3 Company Landscape
3.1 Top Preventable Vaccines Players in Global Market
3.2 Top Global Preventable Vaccines Companies Ranked by Revenue
3.3 Global Preventable Vaccines Revenue by Companies
3.4 Global Preventable Vaccines Sales by Companies
3.5 Global Preventable Vaccines Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Preventable Vaccines Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Preventable Vaccines Product Type
3.8 Tier 1, Tier 2 and Tier 3 Preventable Vaccines Players in Global Market
3.8.1 List of Global Tier 1 Preventable Vaccines Companies
3.8.2 List of Global Tier 2 and Tier 3 Preventable Vaccines Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Preventable Vaccines Market Size Markets, 2022 & 2029
4.1.2 Adult Preventable Vaccines
4.1.3 Pediatric Preventable Vaccines
4.2 By Type - Global Preventable Vaccines Revenue & Forecasts
4.2.1 By Type - Global Preventable Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Preventable Vaccines Revenue, 2024-2029
4.2.3 By Type - Global Preventable Vaccines Revenue Market Share, 2018-2029
4.3 By Type - Global Preventable Vaccines Sales & Forecasts
4.3.1 By Type - Global Preventable Vaccines Sales, 2018-2023
4.3.2 By Type - Global Preventable Vaccines Sales, 2024-2029
4.3.3 By Type - Global Preventable Vaccines Sales Market Share, 2018-2029
4.4 By Type - Global Preventable Vaccines Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Preventable Vaccines Market Size, 2022 & 2029
5.1.2 Bacterial Diseases
5.1.3 Virus Diseases
5.2 By Application - Global Preventable Vaccines Revenue & Forecasts
5.2.1 By Application - Global Preventable Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Preventable Vaccines Revenue, 2024-2029
5.2.3 By Application - Global Preventable Vaccines Revenue Market Share, 2018-2029
5.3 By Application - Global Preventable Vaccines Sales & Forecasts
5.3.1 By Application - Global Preventable Vaccines Sales, 2018-2023
5.3.2 By Application - Global Preventable Vaccines Sales, 2024-2029
5.3.3 By Application - Global Preventable Vaccines Sales Market Share, 2018-2029
5.4 By Application - Global Preventable Vaccines Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Preventable Vaccines Market Size, 2022 & 2029
6.2 By Region - Global Preventable Vaccines Revenue & Forecasts
6.2.1 By Region - Global Preventable Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Preventable Vaccines Revenue, 2024-2029
6.2.3 By Region - Global Preventable Vaccines Revenue Market Share, 2018-2029
6.3 By Region - Global Preventable Vaccines Sales & Forecasts
6.3.1 By Region - Global Preventable Vaccines Sales, 2018-2023
6.3.2 By Region - Global Preventable Vaccines Sales, 2024-2029
6.3.3 By Region - Global Preventable Vaccines Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Preventable Vaccines Revenue, 2018-2029
6.4.2 By Country - North America Preventable Vaccines Sales, 2018-2029
6.4.3 US Preventable Vaccines Market Size, 2018-2029
6.4.4 Canada Preventable Vaccines Market Size, 2018-2029
6.4.5 Mexico Preventable Vaccines Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Preventable Vaccines Revenue, 2018-2029
6.5.2 By Country - Europe Preventable Vaccines Sales, 2018-2029
6.5.3 Germany Preventable Vaccines Market Size, 2018-2029
6.5.4 France Preventable Vaccines Market Size, 2018-2029
6.5.5 U.K. Preventable Vaccines Market Size, 2018-2029
6.5.6 Italy Preventable Vaccines Market Size, 2018-2029
6.5.7 Russia Preventable Vaccines Market Size, 2018-2029
6.5.8 Nordic Countries Preventable Vaccines Market Size, 2018-2029
6.5.9 Benelux Preventable Vaccines Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Preventable Vaccines Revenue, 2018-2029
6.6.2 By Region - Asia Preventable Vaccines Sales, 2018-2029
6.6.3 China Preventable Vaccines Market Size, 2018-2029
6.6.4 Japan Preventable Vaccines Market Size, 2018-2029
6.6.5 South Korea Preventable Vaccines Market Size, 2018-2029
6.6.6 Southeast Asia Preventable Vaccines Market Size, 2018-2029
6.6.7 India Preventable Vaccines Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Preventable Vaccines Revenue, 2018-2029
6.7.2 By Country - South America Preventable Vaccines Sales, 2018-2029
6.7.3 Brazil Preventable Vaccines Market Size, 2018-2029
6.7.4 Argentina Preventable Vaccines Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Preventable Vaccines Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Preventable Vaccines Sales, 2018-2029
6.8.3 Turkey Preventable Vaccines Market Size, 2018-2029
6.8.4 Israel Preventable Vaccines Market Size, 2018-2029
6.8.5 Saudi Arabia Preventable Vaccines Market Size, 2018-2029
6.8.6 UAE Preventable Vaccines Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Company Summary
7.1.2 GlaxoSmithKline Business Overview
7.1.3 GlaxoSmithKline Preventable Vaccines Major Product Offerings
7.1.4 GlaxoSmithKline Preventable Vaccines Sales and Revenue in Global (2018-2023)
7.1.5 GlaxoSmithKline Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Preventable Vaccines Major Product Offerings
7.2.4 Merck Preventable Vaccines Sales and Revenue in Global (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Preventable Vaccines Major Product Offerings
7.3.4 Novartis Preventable Vaccines Sales and Revenue in Global (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Preventable Vaccines Major Product Offerings
7.4.4 Pfizer Preventable Vaccines Sales and Revenue in Global (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 Sanofi
7.5.1 Sanofi Company Summary
7.5.2 Sanofi Business Overview
7.5.3 Sanofi Preventable Vaccines Major Product Offerings
7.5.4 Sanofi Preventable Vaccines Sales and Revenue in Global (2018-2023)
7.5.5 Sanofi Key News & Latest Developments
7.6 Takeda Pharmaceutical
7.6.1 Takeda Pharmaceutical Company Summary
7.6.2 Takeda Pharmaceutical Business Overview
7.6.3 Takeda Pharmaceutical Preventable Vaccines Major Product Offerings
7.6.4 Takeda Pharmaceutical Preventable Vaccines Sales and Revenue in Global (2018-2023)
7.6.5 Takeda Pharmaceutical Key News & Latest Developments
7.7 Abbott
7.7.1 Abbott Company Summary
7.7.2 Abbott Business Overview
7.7.3 Abbott Preventable Vaccines Major Product Offerings
7.7.4 Abbott Preventable Vaccines Sales and Revenue in Global (2018-2023)
7.7.5 Abbott Key News & Latest Developments
7.8 Roche
7.8.1 Roche Company Summary
7.8.2 Roche Business Overview
7.8.3 Roche Preventable Vaccines Major Product Offerings
7.8.4 Roche Preventable Vaccines Sales and Revenue in Global (2018-2023)
7.8.5 Roche Key News & Latest Developments
7.9 AstraZeneca
7.9.1 AstraZeneca Company Summary
7.9.2 AstraZeneca Business Overview
7.9.3 AstraZeneca Preventable Vaccines Major Product Offerings
7.9.4 AstraZeneca Preventable Vaccines Sales and Revenue in Global (2018-2023)
7.9.5 AstraZeneca Key News & Latest Developments
7.10 Mitsubishi Tanabe Pharma
7.10.1 Mitsubishi Tanabe Pharma Company Summary
7.10.2 Mitsubishi Tanabe Pharma Business Overview
7.10.3 Mitsubishi Tanabe Pharma Preventable Vaccines Major Product Offerings
7.10.4 Mitsubishi Tanabe Pharma Preventable Vaccines Sales and Revenue in Global (2018-2023)
7.10.5 Mitsubishi Tanabe Pharma Key News & Latest Developments
7.11 Lupin
7.11.1 Lupin Company Summary
7.11.2 Lupin Preventable Vaccines Business Overview
7.11.3 Lupin Preventable Vaccines Major Product Offerings
7.11.4 Lupin Preventable Vaccines Sales and Revenue in Global (2018-2023)
7.11.5 Lupin Key News & Latest Developments
7.12 Serum Institute of India
7.12.1 Serum Institute of India Company Summary
7.12.2 Serum Institute of India Preventable Vaccines Business Overview
7.12.3 Serum Institute of India Preventable Vaccines Major Product Offerings
7.12.4 Serum Institute of India Preventable Vaccines Sales and Revenue in Global (2018-2023)
7.12.5 Serum Institute of India Key News & Latest Developments
7.13 LG Life Sciences
7.13.1 LG Life Sciences Company Summary
7.13.2 LG Life Sciences Preventable Vaccines Business Overview
7.13.3 LG Life Sciences Preventable Vaccines Major Product Offerings
7.13.4 LG Life Sciences Preventable Vaccines Sales and Revenue in Global (2018-2023)
7.13.5 LG Life Sciences Key News & Latest Developments
7.14 S K Chemicals
7.14.1 S K Chemicals Company Summary
7.14.2 S K Chemicals Business Overview
7.14.3 S K Chemicals Preventable Vaccines Major Product Offerings
7.14.4 S K Chemicals Preventable Vaccines Sales and Revenue in Global (2018-2023)
7.14.5 S K Chemicals Key News & Latest Developments
7.15 Shenzhen Kangtai Biological Products
7.15.1 Shenzhen Kangtai Biological Products Company Summary
7.15.2 Shenzhen Kangtai Biological Products Business Overview
7.15.3 Shenzhen Kangtai Biological Products Preventable Vaccines Major Product Offerings
7.15.4 Shenzhen Kangtai Biological Products Preventable Vaccines Sales and Revenue in Global (2018-2023)
7.15.5 Shenzhen Kangtai Biological Products Key News & Latest Developments
7.16 Sinovac Biotech
7.16.1 Sinovac Biotech Company Summary
7.16.2 Sinovac Biotech Business Overview
7.16.3 Sinovac Biotech Preventable Vaccines Major Product Offerings
7.16.4 Sinovac Biotech Preventable Vaccines Sales and Revenue in Global (2018-2023)
7.16.5 Sinovac Biotech Key News & Latest Developments
7.17 Janssen Pharmaceuticals
7.17.1 Janssen Pharmaceuticals Company Summary
7.17.2 Janssen Pharmaceuticals Business Overview
7.17.3 Janssen Pharmaceuticals Preventable Vaccines Major Product Offerings
7.17.4 Janssen Pharmaceuticals Preventable Vaccines Sales and Revenue in Global (2018-2023)
7.17.5 Janssen Pharmaceuticals Key News & Latest Developments
7.18 Crucell
7.18.1 Crucell Company Summary
7.18.2 Crucell Business Overview
7.18.3 Crucell Preventable Vaccines Major Product Offerings
7.18.4 Crucell Preventable Vaccines Sales and Revenue in Global (2018-2023)
7.18.5 Crucell Key News & Latest Developments
7.19 Bavarian Nordic
7.19.1 Bavarian Nordic Company Summary
7.19.2 Bavarian Nordic Business Overview
7.19.3 Bavarian Nordic Preventable Vaccines Major Product Offerings
7.19.4 Bavarian Nordic Preventable Vaccines Sales and Revenue in Global (2018-2023)
7.19.5 Bavarian Nordic Key News & Latest Developments
7.20 Baxter
7.20.1 Baxter Company Summary
7.20.2 Baxter Business Overview
7.20.3 Baxter Preventable Vaccines Major Product Offerings
7.20.4 Baxter Preventable Vaccines Sales and Revenue in Global (2018-2023)
7.20.5 Baxter Key News & Latest Developments
7.21 Bharat Biotech
7.21.1 Bharat Biotech Company Summary
7.21.2 Bharat Biotech Business Overview
7.21.3 Bharat Biotech Preventable Vaccines Major Product Offerings
7.21.4 Bharat Biotech Preventable Vaccines Sales and Revenue in Global (2018-2023)
7.21.5 Bharat Biotech Key News & Latest Developments
7.22 Dynavax
7.22.1 Dynavax Company Summary
7.22.2 Dynavax Business Overview
7.22.3 Dynavax Preventable Vaccines Major Product Offerings
7.22.4 Dynavax Preventable Vaccines Sales and Revenue in Global (2018-2023)
7.22.5 Dynavax Key News & Latest Developments
7.23 Bausch Health
7.23.1 Bausch Health Company Summary
7.23.2 Bausch Health Business Overview
7.23.3 Bausch Health Preventable Vaccines Major Product Offerings
7.23.4 Bausch Health Preventable Vaccines Sales and Revenue in Global (2018-2023)
7.23.5 Bausch Health Key News & Latest Developments
7.24 Protein Sciences
7.24.1 Protein Sciences Company Summary
7.24.2 Protein Sciences Business Overview
7.24.3 Protein Sciences Preventable Vaccines Major Product Offerings
7.24.4 Protein Sciences Preventable Vaccines Sales and Revenue in Global (2018-2023)
7.24.5 Protein Sciences Key News & Latest Developments
7.25 Panacea Biotec
7.25.1 Panacea Biotec Company Summary
7.25.2 Panacea Biotec Business Overview
7.25.3 Panacea Biotec Preventable Vaccines Major Product Offerings
7.25.4 Panacea Biotec Preventable Vaccines Sales and Revenue in Global (2018-2023)
7.25.5 Panacea Biotec Key News & Latest Developments
8 Global Preventable Vaccines Production Capacity, Analysis
8.1 Global Preventable Vaccines Production Capacity, 2018-2029
8.2 Preventable Vaccines Production Capacity of Key Manufacturers in Global Market
8.3 Global Preventable Vaccines Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Preventable Vaccines Supply Chain Analysis
10.1 Preventable Vaccines Industry Value Chain
10.2 Preventable Vaccines Upstream Market
10.3 Preventable Vaccines Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Preventable Vaccines Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Preventable Vaccines in Global Market
Table 2. Top Preventable Vaccines Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Preventable Vaccines Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Preventable Vaccines Revenue Share by Companies, 2018-2023
Table 5. Global Preventable Vaccines Sales by Companies, (K Units), 2018-2023
Table 6. Global Preventable Vaccines Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Preventable Vaccines Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Preventable Vaccines Product Type
Table 9. List of Global Tier 1 Preventable Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Preventable Vaccines Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Preventable Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Preventable Vaccines Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Preventable Vaccines Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Preventable Vaccines Sales (K Units), 2018-2023
Table 15. By Type - Global Preventable Vaccines Sales (K Units), 2024-2029
Table 16. By Application ? Global Preventable Vaccines Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Preventable Vaccines Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Preventable Vaccines Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Preventable Vaccines Sales (K Units), 2018-2023
Table 20. By Application - Global Preventable Vaccines Sales (K Units), 2024-2029
Table 21. By Region ? Global Preventable Vaccines Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Preventable Vaccines Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Preventable Vaccines Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Preventable Vaccines Sales (K Units), 2018-2023
Table 25. By Region - Global Preventable Vaccines Sales (K Units), 2024-2029
Table 26. By Country - North America Preventable Vaccines Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Preventable Vaccines Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Preventable Vaccines Sales, (K Units), 2018-2023
Table 29. By Country - North America Preventable Vaccines Sales, (K Units), 2024-2029
Table 30. By Country - Europe Preventable Vaccines Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Preventable Vaccines Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Preventable Vaccines Sales, (K Units), 2018-2023
Table 33. By Country - Europe Preventable Vaccines Sales, (K Units), 2024-2029
Table 34. By Region - Asia Preventable Vaccines Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Preventable Vaccines Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Preventable Vaccines Sales, (K Units), 2018-2023
Table 37. By Region - Asia Preventable Vaccines Sales, (K Units), 2024-2029
Table 38. By Country - South America Preventable Vaccines Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Preventable Vaccines Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Preventable Vaccines Sales, (K Units), 2018-2023
Table 41. By Country - South America Preventable Vaccines Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Preventable Vaccines Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Preventable Vaccines Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Preventable Vaccines Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Preventable Vaccines Sales, (K Units), 2024-2029
Table 46. GlaxoSmithKline Company Summary
Table 47. GlaxoSmithKline Preventable Vaccines Product Offerings
Table 48. GlaxoSmithKline Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. GlaxoSmithKline Key News & Latest Developments
Table 50. Merck Company Summary
Table 51. Merck Preventable Vaccines Product Offerings
Table 52. Merck Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Merck Key News & Latest Developments
Table 54. Novartis Company Summary
Table 55. Novartis Preventable Vaccines Product Offerings
Table 56. Novartis Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 57. Novartis Key News & Latest Developments
Table 58. Pfizer Company Summary
Table 59. Pfizer Preventable Vaccines Product Offerings
Table 60. Pfizer Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 61. Pfizer Key News & Latest Developments
Table 62. Sanofi Company Summary
Table 63. Sanofi Preventable Vaccines Product Offerings
Table 64. Sanofi Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 65. Sanofi Key News & Latest Developments
Table 66. Takeda Pharmaceutical Company Summary
Table 67. Takeda Pharmaceutical Preventable Vaccines Product Offerings
Table 68. Takeda Pharmaceutical Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 69. Takeda Pharmaceutical Key News & Latest Developments
Table 70. Abbott Company Summary
Table 71. Abbott Preventable Vaccines Product Offerings
Table 72. Abbott Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 73. Abbott Key News & Latest Developments
Table 74. Roche Company Summary
Table 75. Roche Preventable Vaccines Product Offerings
Table 76. Roche Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 77. Roche Key News & Latest Developments
Table 78. AstraZeneca Company Summary
Table 79. AstraZeneca Preventable Vaccines Product Offerings
Table 80. AstraZeneca Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 81. AstraZeneca Key News & Latest Developments
Table 82. Mitsubishi Tanabe Pharma Company Summary
Table 83. Mitsubishi Tanabe Pharma Preventable Vaccines Product Offerings
Table 84. Mitsubishi Tanabe Pharma Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 85. Mitsubishi Tanabe Pharma Key News & Latest Developments
Table 86. Lupin Company Summary
Table 87. Lupin Preventable Vaccines Product Offerings
Table 88. Lupin Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 89. Lupin Key News & Latest Developments
Table 90. Serum Institute of India Company Summary
Table 91. Serum Institute of India Preventable Vaccines Product Offerings
Table 92. Serum Institute of India Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 93. Serum Institute of India Key News & Latest Developments
Table 94. LG Life Sciences Company Summary
Table 95. LG Life Sciences Preventable Vaccines Product Offerings
Table 96. LG Life Sciences Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 97. LG Life Sciences Key News & Latest Developments
Table 98. S K Chemicals Company Summary
Table 99. S K Chemicals Preventable Vaccines Product Offerings
Table 100. S K Chemicals Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 101. S K Chemicals Key News & Latest Developments
Table 102. Shenzhen Kangtai Biological Products Company Summary
Table 103. Shenzhen Kangtai Biological Products Preventable Vaccines Product Offerings
Table 104. Shenzhen Kangtai Biological Products Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 105. Shenzhen Kangtai Biological Products Key News & Latest Developments
Table 106. Sinovac Biotech Company Summary
Table 107. Sinovac Biotech Preventable Vaccines Product Offerings
Table 108. Sinovac Biotech Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 109. Sinovac Biotech Key News & Latest Developments
Table 110. Janssen Pharmaceuticals Company Summary
Table 111. Janssen Pharmaceuticals Preventable Vaccines Product Offerings
Table 112. Janssen Pharmaceuticals Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 113. Janssen Pharmaceuticals Key News & Latest Developments
Table 114. Crucell Company Summary
Table 115. Crucell Preventable Vaccines Product Offerings
Table 116. Crucell Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 117. Crucell Key News & Latest Developments
Table 118. Bavarian Nordic Company Summary
Table 119. Bavarian Nordic Preventable Vaccines Product Offerings
Table 120. Bavarian Nordic Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 121. Bavarian Nordic Key News & Latest Developments
Table 122. Baxter Company Summary
Table 123. Baxter Preventable Vaccines Product Offerings
Table 124. Baxter Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 125. Baxter Key News & Latest Developments
Table 126. Bharat Biotech Company Summary
Table 127. Bharat Biotech Preventable Vaccines Product Offerings
Table 128. Bharat Biotech Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 129. Bharat Biotech Key News & Latest Developments
Table 130. Dynavax Company Summary
Table 131. Dynavax Preventable Vaccines Product Offerings
Table 132. Dynavax Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 133. Dynavax Key News & Latest Developments
Table 134. Bausch Health Company Summary
Table 135. Bausch Health Preventable Vaccines Product Offerings
Table 136. Bausch Health Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 137. Bausch Health Key News & Latest Developments
Table 138. Protein Sciences Company Summary
Table 139. Protein Sciences Preventable Vaccines Product Offerings
Table 140. Protein Sciences Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 141. Protein Sciences Key News & Latest Developments
Table 142. Panacea Biotec Company Summary
Table 143. Panacea Biotec Preventable Vaccines Product Offerings
Table 144. Panacea Biotec Preventable Vaccines Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 145. Panacea Biotec Key News & Latest Developments
Table 146. Preventable Vaccines Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 147. Global Preventable Vaccines Capacity Market Share of Key Manufacturers, 2021-2023
Table 148. Global Preventable Vaccines Production by Region, 2018-2023 (K Units)
Table 149. Global Preventable Vaccines Production by Region, 2024-2029 (K Units)
Table 150. Preventable Vaccines Market Opportunities & Trends in Global Market
Table 151. Preventable Vaccines Market Drivers in Global Market
Table 152. Preventable Vaccines Market Restraints in Global Market
Table 153. Preventable Vaccines Raw Materials
Table 154. Preventable Vaccines Raw Materials Suppliers in Global Market
Table 155. Typical Preventable Vaccines Downstream
Table 156. Preventable Vaccines Downstream Clients in Global Market
Table 157. Preventable Vaccines Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Preventable Vaccines Segment by Type in 2022
Figure 2. Preventable Vaccines Segment by Application in 2022
Figure 3. Global Preventable Vaccines Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Preventable Vaccines Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Preventable Vaccines Revenue, 2018-2029 (US$, Mn)
Figure 7. Preventable Vaccines Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Preventable Vaccines Revenue in 2022
Figure 9. By Type - Global Preventable Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Preventable Vaccines Revenue Market Share, 2018-2029
Figure 11. By Type - Global Preventable Vaccines Sales Market Share, 2018-2029
Figure 12. By Type - Global Preventable Vaccines Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Preventable Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Preventable Vaccines Revenue Market Share, 2018-2029
Figure 15. By Application - Global Preventable Vaccines Sales Market Share, 2018-2029
Figure 16. By Application - Global Preventable Vaccines Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Preventable Vaccines Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Preventable Vaccines Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Preventable Vaccines Revenue Market Share, 2018-2029
Figure 20. By Region - Global Preventable Vaccines Sales Market Share, 2018-2029
Figure 21. By Country - North America Preventable Vaccines Revenue Market Share, 2018-2029
Figure 22. By Country - North America Preventable Vaccines Sales Market Share, 2018-2029
Figure 23. US Preventable Vaccines Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Preventable Vaccines Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Preventable Vaccines Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Preventable Vaccines Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Preventable Vaccines Sales Market Share, 2018-2029
Figure 28. Germany Preventable Vaccines Revenue, (US$, Mn), 2018-2029
Figure 29. France Preventable Vaccines Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Preventable Vaccines Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Preventable Vaccines Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Preventable Vaccines Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Preventable Vaccines Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Preventable Vaccines Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Preventable Vaccines Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Preventable Vaccines Sales Market Share, 2018-2029
Figure 37. China Preventable Vaccines Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Preventable Vaccines Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Preventable Vaccines Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Preventable Vaccines Revenue, (US$, Mn), 2018-2029
Figure 41. India Preventable Vaccines Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Preventable Vaccines Revenue Market Share, 2018-2029
Figure 43. By Country - South America Preventable Vaccines Sales Market Share, 2018-2029
Figure 44. Brazil Preventable Vaccines Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Preventable Vaccines Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Preventable Vaccines Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Preventable Vaccines Sales Market Share, 2018-2029
Figure 48. Turkey Preventable Vaccines Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Preventable Vaccines Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Preventable Vaccines Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Preventable Vaccines Revenue, (US$, Mn), 2018-2029
Figure 52. Global Preventable Vaccines Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Preventable Vaccines by Region, 2022 VS 2029
Figure 54. Preventable Vaccines Industry Value Chain
Figure 55. Marketing Channels
